Oz Management LP Has Boosted Charles Riv Labs Intl INC (CRL) Position by $10.96 Million

Charles River Laboratories International, Inc. (NYSE:CRL) LogoInvestors sentiment increased to 1.06 in 2019 Q2. Its up 0.19, from 0.87 in 2019Q1. It improved, as 31 investors sold CRL shares while 117 reduced holdings. 49 funds opened positions while 108 raised stakes. 45.51 million shares or 0.90% more from 45.11 million shares in 2019Q1 were reported. Glenmede Trust Na holds 0% of its portfolio in Charles River Laboratories International, Inc. (NYSE:CRL) for 439 shares. Copper Rock Ltd Liability Corp holds 1.97% of its portfolio in Charles River Laboratories International, Inc. (NYSE:CRL) for 187,521 shares. Amalgamated National Bank reported 11,100 shares or 0.04% of all its holdings. The New York-based Jennison Assoc Limited Liability Co has invested 0% in Charles River Laboratories International, Inc. (NYSE:CRL). The Maryland-based Profund Advisors has invested 0.11% in Charles River Laboratories International, Inc. (NYSE:CRL). Gam Holding Ag has 0.03% invested in Charles River Laboratories International, Inc. (NYSE:CRL). 702,865 are owned by Congress Asset Mgmt Communication Ma. Nuveen Asset Mgmt Llc holds 0.01% of its portfolio in Charles River Laboratories International, Inc. (NYSE:CRL) for 203,189 shares. Palisade Capital Ltd Limited Liability Company Nj holds 0.02% or 3,484 shares. 545,284 are held by Voya Invest Management Limited Liability Corp. Arizona State Retirement System holds 0.06% or 35,385 shares in its portfolio. Clarivest Asset Management Llc invested 0.27% of its portfolio in Charles River Laboratories International, Inc. (NYSE:CRL). Morgan Stanley reported 0.01% of its portfolio in Charles River Laboratories International, Inc. (NYSE:CRL). Gsa Cap Prns Llp has 0.2% invested in Charles River Laboratories International, Inc. (NYSE:CRL). 143,260 were accumulated by Btim.

Oz Management Lp increased its stake in Charles Riv Labs Intl Inc (CRL) by 25.47% based on its latest 2019Q2 regulatory filing with the SEC. Oz Management Lp bought 77,700 shares as the company’s stock declined 2.05% . The hedge fund held 382,746 shares of the health care company at the end of 2019Q2, valued at $54.31M, up from 305,046 at the end of the previous reported quarter. Oz Management Lp who had been investing in Charles Riv Labs Intl Inc for a number of months, seems to be bullish on the $6.52 billion market cap company. The stock increased 0.35% or $0.46 during the last trading session, reaching $132.25. About 496,775 shares traded or 51.18% up from the average. Charles River Laboratories International, Inc. (NYSE:CRL) has risen 11.21% since September 13, 2018 and is uptrending. It has outperformed by 11.21% the S&P500.

Oz Management Lp, which manages about $56.28B and $18.76B US Long portfolio, decreased its stake in Wynn Resorts Ltd (NASDAQ:WYNN) by 726,507 shares to 1.60 million shares, valued at $198.61 million in 2019Q2, according to the filing. It also reduced its holding in Crown Castle Intl Corp New by 28,000 shares in the quarter, leaving it with 43,585 shares, and cut its stake in Lowes Cos Inc (NYSE:LOW).

More notable recent Charles River Laboratories International, Inc. (NYSE:CRL) news were published by: Seekingalpha.com which released: “Charles River Laboratories Q2 2019 Earnings Preview – Seeking Alpha” on July 30, 2019, also Globenewswire.com with their article: “Bragar Eagel & Squire, PC is Investigating Charles River Laboratories International, Inc. (CRL) on Behalf of Stockholders and Encourages CRL Investors to Contact the Firm – GlobeNewswire” published on May 02, 2019, Businesswire.com published: “Charles River Laboratories Announces Updates to Microbial Solutions Product Portfolio – Business Wire” on September 09, 2019. More interesting news about Charles River Laboratories International, Inc. (NYSE:CRL) were released by: Businesswire.com and their article: “Charles River and Distributed Bio Enter Exclusive Partnership to Create an Integrated Antibody Discovery and Development Platform – Business Wire” published on October 25, 2018 as well as Seekingalpha.com‘s news article titled: “Charles River Laboratories International, Inc. 2019 Q1 – Results – Earnings Call Slides – Seeking Alpha” with publication date: May 07, 2019.

Charles River Laboratories International, Inc. (NYSE:CRL) Ratings Coverage

Among 2 analysts covering Charles River Labs (NYSE:CRL), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Charles River Labs has $170 highest and $145 lowest target. $157.50’s average target is 19.09% above currents $132.25 stock price. Charles River Labs had 4 analyst reports since March 14, 2019 according to SRatingsIntel. The firm earned “Hold” rating on Monday, March 18 by Barclays Capital. The firm has “Buy” rating given on Thursday, March 14 by Argus Research.

Charles River Laboratories International, Inc. (NYSE:CRL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.